Shenyang He Eye Specialist Hospital, Shenyang, China.
He University, Shenyang, China.
Mol Genet Genomic Med. 2020 Apr;8(4):e1184. doi: 10.1002/mgg3.1184. Epub 2020 Feb 26.
Panel-based targeted exome sequencing was used to analyze the genetic and clinical findings of targeted genes in a cohort of northeast Chinese with retinitis pigmentosa.
A total of 87 subjects, comprising 23 probands and their family members (total patients: 32) with confirmed retinitis pigmentosa were recruited in the study. Panel-based targeted exome sequencing was used to sequence the patients and family members, all subjects with retinitis pigmentosa underwent a complete ophthalmologic examination.
Of the 23 probands, the clinical manifestations include night blindness, narrowing of vision, secondary cataracts, choroidal atrophy, color blindness, and high myopia, the average age of onset of night blindness is 12.9 ± 14 (range, 0-65; median, 8). Posterior subcapsular opacities is the most common forms of secondary cataracts (nine cases, 39.1%), and peripheral choroidal atrophy is the most common form of secondary choroidal atrophy (12 cases, 52.2%). Of these probands with complication peripheral choroidal atrophy, there were eight probands (66.7%, 8/12) caused by the pathogenic variation in USH2A gene. A total of 17 genes and 45 variants were detected in 23 probands. Among these genes, the commonest genes were USH2A (40%; 18/45), RP1 (15.6%; 7/45), and EYS (8.9%; 4/45), and the top three genes account for 56.5% (13/23) of diagnostic probands. Among these variants, comprising 22 (48.9%) pathogenic variants, 14 (31%) likely pathogenic variants, and nine (20%) uncertain clinical significance variants, and 22 variants was discovered first time. Most of the mutations associated with RP were missense (53.3%, 24/45), and the remaining mutation types include frameshift (35.6%, 16/45), nonsense (6.7%, 3/45), and spliceSite (4.4%, 2/45). Among the probands with mutations detected, compound heterozygous forms was detected in 13 (56.5%, 13/23) probands, and digenic inheritance (DI) forms was detected in five (21.7%, 5/23) probands.
Panel-based targeted exome sequencing revealed 23 novel mutations, recognized different combinations forms of variants, and extended the mutational spectrum of retinitis pigmentosa and depicted common variants in northeast China.
采用基于panel 的靶向外显子测序分析了一组中国东北视网膜色素变性患者的靶向基因的遗传和临床发现。
共招募了 87 名受试者,包括 23 名先证者及其家系成员(总患者:32 名),所有视网膜色素变性患者均进行了全面的眼科检查。采用基于 panel 的靶向外显子测序对患者和家系成员进行测序。
23 名先证者的临床表现包括夜盲、视野变窄、继发性白内障、脉络膜萎缩、色盲和高度近视,夜盲的平均发病年龄为 12.9±14 岁(范围,0-65 岁;中位数,8 岁)。继发性白内障最常见的形式是后囊下混浊(9 例,39.1%),继发性脉络膜萎缩最常见的形式是周边脉络膜萎缩(12 例,52.2%)。在这些伴有并发症的周边脉络膜萎缩的先证者中,有 8 例(66.7%,8/12)是由 USH2A 基因突变引起的。在 23 名先证者中共检测到 17 个基因和 45 个变异。其中,常见的基因是 USH2A(40%,18/45)、RP1(15.6%,7/45)和 EYS(8.9%,4/45),前三个基因占诊断先证者的 56.5%(13/23)。在这些变异中,包括 22 个(48.9%)致病性变异、14 个(31%)可能致病性变异和 9 个(20%)不确定临床意义的变异,其中 22 个变异是首次发现。与 RP 相关的大多数突变是错义(53.3%,24/45),其余的突变类型包括移码(35.6%,16/45)、无义(6.7%,3/45)和剪接位点(4.4%,2/45)。在检测到突变的先证者中,13 名(56.5%,13/23)先证者为复合杂合形式,5 名(21.7%,5/23)先证者为双基因遗传(DI)形式。
基于 panel 的靶向外显子测序揭示了 23 个新突变,识别了不同的变异组合形式,扩展了视网膜色素变性的突变谱,并描绘了中国东北的常见变异。